|
1
|
Riaz MK, Zhang X, Wong KH, Chen H, Liu Q,
Chen X, Zhang G, Lu A and Yang Z: Pulmonary delivery of transferrin
receptors targeting peptide surface-functionalized liposomes
augments the chemotherapeutic effect of quercetin in lung cancer
therapy. Int J Nanomedicine. 14:2879–2902. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Romero-Vielva L, Viteri S, Moya-Horno I,
Toscas JI, Maestre-Alcácer JA, Ramón Y, Cajal S and Rosell R:
Salvage surgery after definitive chemo-radiotherapy for patients
with non-Small cell lung cancer. Lung Cancer. 133:117–122. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen QY, Jiao DM, Wang J, Hu H, Tang X,
Chen J, Mou H and Lu W: miR-206 regulates cisplatin resistance and
EMT in human lung adenocarcinoma cells partly by targeting MET.
Oncotarget. 7:24510–24526. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo L, Song P, Xue X, Guo C, Han L, Fang
Q, Ying J, Gao S and Li W: Variation of programmed death ligand 1
expression after platinum-based neoadjuvant chemotherapy in lung
cancer. J Immunother. 42:215–220. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang Q, Zhang Z, Xu H and Ma C: Lidocaine
alleviates cytotoxicity-resistance in lung cancer A549/DDP cells
via down-regulation of miR-21. Mol Cell Biochem. 456:63–72. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martens-Uzunova ES, Böttcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan JJ, Xie XJ, Li X and Chen W: Long
non-coding RNAs and drug resistance. Asian Pac J Cancer Prev.
16:8067–8073. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Z, Zhu Z, Watabe K, Zhang X, Bai C,
Xu M, Wu F and Mo YY: Negative regulation of lncRNA GAS5 by miR-21.
Cell Death Differ. 20:1558–1568. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tano K and Akimitsu N: Long non-coding
RNAs in cancer progression. Front Genet. 3:2192012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang EB, Kong R, Yin DD, You LH, Sun M,
Han L, Xu TP, Xia R, Yang JS, De W and Chen Jf: Long noncoding RNA
ANRIL indicates a poor prognosis of gastric cancer and promotes
tumor growth by epigenetically silencing of miR-99a/miR-449a.
Oncotarget. 5:2276–2292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia
R, Liu YW, Liu XH, Zhang EB, Lu K and Shu YQ: Long noncoding RNA
ANRIL promotes non-small cell lung cancer cell proliferation and
inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer
Ther. 14:268–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iranpour M, Soudyab M, Geranpayeh L,
Mirfakhraie R, Azargashb E, Movafagh A and Ghafouri-Fard S:
Expression analysis of four long noncoding RNAs in breast cancer.
Tumour Biol. 37:2933–2940. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wan G, Mathur R, Hu X, Liu Y, Zhang X,
Peng G and Lu X: Long non-coding RNA ANRIL (CDKN2B-AS) is induced
by the ATM-E2F1 signaling pathway. Cell Signal. 25:1086–1095. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu P, Guo M and Hay BA: MicroRNAs and the
regulation of cell death. Trends Genet. 20:617–624. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma J, Dong C and Ji C: MicroRNA and drug
resistance. Cancer Gene Ther. 17:523–531. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
MacDonagh L, Gray SG, Finn SP, Cuffe S,
O'Byrne KJ and Barr MP: The emerging role of microRNAs in
resistance to lung cancer treatments. Cancer Treat Rev. 41:160–169.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiang Q, Tang H, Yu J, Yin J, Yang X and
Lei X: MicroRNA-98 sensitizes cisplatin-resistant human lung
adenocarcinoma cells by up-regulation of HMGA2. Pharmazie.
68:274–281. 2013.PubMed/NCBI
|
|
21
|
Ren K, Li Y, Lu H, Li Z, Li Z, Wu K, Li Z
and Han X: Long noncoding RNA HOTAIR controls cell cycle by
functioning as a competing endogenous RNA in esophageal squamous
cell carcinoma. Transl Oncol. 9:489–497. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xia H and Hui KM: Mechanism of cancer drug
resistance and the involvement of noncoding RNAs. Curr Med Chem.
21:3029–3041. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen QN, Wei CC, Wang ZX and Sun M: Long
non-coding RNAs in anti-cancer drug resistance. Oncotarget.
8:1925–1936. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi H, Pu J, Zhou XL, Ning YY and Bai C:
Silencing long non-coding RNA ROR improves sensitivity of
non-small-cell lung cancer to cisplatin resistance by inhibiting
PI3K/Akt/mTOR signaling pathway. Tumour Biol.
39:10104283176975682017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu MY, Li XQ, Gao TH, Cui Y, Ma N, Zhou Y
and Zhang GJ: Elevated HOTAIR expression associated with cisplatin
resistance in non-small cell lung cancer patients. J Thorac Dis.
8:3314–3322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xia Y, He Z, Liu B, Wang P and Chen Y:
Downregulation of Meg3 enhances cisplatin resistance of lung cancer
cells through activation of the WNT/β-catenin signaling pathway.
Mol Med Rep. 12:4530–4537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu X, Jiang H and Jiang X: Downregulation
of lncRNA ANRIL inhibits proliferation, induces apoptosis, and
enhances radiosensitivity in nasopharyngeal carcinoma cells through
regulating miR-125a. Cancer Biol Ther. 18:331–338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Cheng N and Luo J: Downregulation
of lncRNA ANRIL represses tumorigenicity and enhances
cisplatin-induced cytotoxicity via regulating microRNA let-7a in
nasopharyngeal carcinoma. J Biochem Mol Toxicol. 31:e219042017.
View Article : Google Scholar
|
|
30
|
Lan WG, Xu DH, Xu C, Ding CL, Ning FL,
Zhou YL, Ma LB, Liu CM and Han X: Silencing of long non-coding RNA
ANRIL inhibits the development of multidrug resistance in gastric
cancer cells. Oncol Rep. 36:263–270. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu R, Mao Y, Chen K, He W, Shi W and Han
Y: The long noncoding RNA ANRIL acts as an oncogene and contributes
to paclitaxel resistance of lung adenocarcinoma A549 cells.
Oncotarget. 8:39177–39184. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu
Y, Feng Y, Liu H, Fei B, Mao Y, et al: LncRNA-UCA1 enhances cell
proliferation and 5-fluorouracil resistance in colorectal cancer by
inhibiting miR-204-5p. Sci Rep. 6:238922016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang FT, Chen WY, Gu ZQ, Zhuang YY, Li
CQ, Wang LY, Peng JF, Zhu Z, Luo X, Li YH, et al: The novel long
intergenic noncoding RNA UCC promotes colorectal cancer progression
by sponging miR-143. Cell Death Dis. 8:e27782017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang JJ, Wang DD, Du CX and Wang Y: Long
noncoding RNA ANRIL promotes cervical cancer development by acting
as a sponge of miR-186. Oncol Res. 26:345–352. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang H, Wang X and Chen X: Potential role
of long non-coding RNA ANRIL in pediatric medulloblastoma through
promotion on proliferation and migration by targeting miR-323. J
Cell Biochem. 118:4735–4744. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nickols NG, Nazarian R, Zhao SG, Tan V,
Uzunangelov V, Xia Z, Baertsch R, Neeman E, Gao AC, Thomas GV, et
al: MEK-ERK signaling is a therapeutic target in metastatic
castration resistant prostate cancer. Prostate Cancer Prostatic
Dis. 22:531–538. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Q, Wang C, Wang Y, Sun L, Liu Z, Wang
L, Song T, Yao Y, Liu Q and Tu K: HSCs-derived COMP drives
hepatocellular carcinoma progression by activating MEK/ERK and
PI3K/AKT signaling pathways. J Exp Clin Cancer Res. 37:231. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shroff GS, Viswanathan C, Carter BW,
Benveniste MF, Truong MT and Sabloff BS: Staging lung cancer:
Metastasis. Radiol Clin North Am. 56:411–418. 2018. View Article : Google Scholar : PubMed/NCBI
|
